Related Experiment Video
Updated: Jul 18, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Statins and the vascular endothelial inflammatory response
John Greenwood1, Justin C Mason
1Department of Cell Biology, Institute of Ophthalmology, University College London, London EC1V 9EL, UK. j.greenwood@ucl.ac.uk
Insights
Statins offer more than cholesterol reduction; they possess anti-inflammatory effects beneficial for vascular endothelial cells. These drugs modulate endothelial cell function, impacting inflammatory responses and improving cardiovascular health.
Area of Science:
- Cardiovascular Science
- Immunology
- Pharmacology
Background:
- Statins are primarily prescribed to lower cholesterol levels, treating hyperlipidemia and preventing ischemic heart disease.
- Beyond lipid-lowering, statins exhibit significant immunomodulatory and anti-inflammatory properties.
- Vascular endothelial cells play a key role in inflammatory disease pathogenesis and are a cellular target for statin therapy.
Purpose of the Study:
- To investigate the impact of statins on endothelial cell function.
- To elucidate the mechanisms by which statins exert their therapeutic effects on the endothelium.
- To understand how statins modulate inflammatory responses within the vasculature.
Main Methods:
- Analysis of endothelial cell function following statin treatment.
- Assessment of molecular changes including MHC class II expression, nitric oxide synthase, and fibrinolytic activity.
- Investigation of leukocyte-endothelial cell interactions and inflammatory gene expression.
Main Results:
- Statins were found to attenuate endothelial MHC class II expression.
- Increased endothelial nitric oxide synthase and fibrinolytic activity were observed.
- Statins decreased leukocyte adhesion and transmigration, enhancing endothelial resistance to injury.
- These effects are linked to the modulation of small GTPase function and reduced pro-inflammatory gene expression.
Conclusions:
- Statins' therapeutic benefits extend beyond cholesterol reduction, involving direct actions on endothelial cells.
- Statins modulate endothelial cell functions to exert anti-inflammatory and immunomodulatory effects.
- Targeting endothelial cell function with statins represents a key therapeutic strategy for inflammatory vascular diseases.
Abstract:
Statins reduce cholesterol synthesis and are widely used for the treatment of hyperlipidaemia and ischaemic heart disease. Besides their cholesterol-lowering effects, statins also possess broad immunomodulatory and anti-inflammatory properties. Vascular endothelial cells have a crucial role in the pathogenesis of inflammatory disease, and, alongside leukocytes and antigen-presenting cells, represent a key cellular target for statin therapy. Recent studies investigating how these drugs modify endothelial cell function demonstrate that the therapeutic effect of statins can be attributed, in part, to their action on the endothelium. Accordingly, statins attenuate endothelial MHC class II expression, increase endothelial nitric oxide synthase and fibrinolytic activity, decrease leukocyte adhesion and transmigration, and enhance resistance to local injurious stimuli. Many of these effects are brought about by the modulation of small GTPase function and the downregulation of proinflammatory gene expression.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Inflammation
Inflammatory Response I: Vascular and Cellular
Atherosclerosis I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...